Form 4: Core Scientific Chief Legal Officer Sells 60,000 Shares Under Pre-Arranged Plan
Insider Transaction Report
Core Scientific's Chief Legal and Administrative Officer, Todd M. DuChene, sold 60,000 shares of common stock for approximately $680,000 under a Rule 10b5-1 trading plan.
Summary
- Todd M. DuChene, the Chief Legal and Administrative Officer of Core Scientific, Inc. (CORZ), reported the sale of 60,000 shares of the company's common stock.
- The transaction took place on June 3, 2025.
- The shares were sold at a weighted average price of $11.3314 per share, with individual transaction prices ranging from $11.1473 to $11.6369.
- The total value of the shares sold is approximately $679,884.
- Following this sale, Mr. DuChene's beneficial ownership of Core Scientific common stock stands at 2,100,102 shares.
- The sale was conducted pursuant to a Rule 10b5-1(c) trading plan, indicating it was a pre-scheduled transaction.
Sentiment
Score: 5
Explanation: Neutral. This is a routine disclosure of an insider stock sale, which was pre-planned under a 10b5-1 agreement, mitigating any negative implications typically associated with insider selling.
Positives
- The sale was executed under a Rule 10b5-1(c) plan, which suggests it was pre-scheduled and not based on new, non-public information, potentially mitigating concerns about opportunistic insider selling.
Negatives
- An insider selling shares, even under a 10b5-1 plan, reduces their direct ownership stake in the company.
Future Outlook
N/A
Management Comments
- Todd M. DuChene is identified as the Chief Legal and Administrative Officer of Core Scientific, Inc.
Industry Context
N/A
Stakeholder Impact
- Shareholders: A minor reduction in insider ownership, but the 10b5-1 plan suggests the sale was pre-planned and not based on new, non-public information.
Key Dates
| Date | Description |
|---|---|
| 06/03/2025 | Date of transaction (sale of common stock) |
| 06/04/2025 | Date of Form 4 filing |
Keywords
Core Scientific, CORZ, Todd M. DuChene, Insider Sale, Form 4, SEC Filing, Stock Transaction, Executive Compensation, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.